Mr. Avi Oler joined Onconova’s Management Team in December 2018 as Vice President, Corporate Development and General Counsel and was promoted to Senior Vice President, Corporate Development & General Counsel in January of 2020.
Mr. Oler served most recently as Vice President of Operations and Chief of Staff to the CEO of Spectrum Pharmaceuticals. During his tenure, he was instrumental in the company’s progress and productive licensing activities. He served in varied roles of increasing responsibility, as a member of the executive management team, the corporate development team, and as Head of Alliances and Legal Affairs. Due to a series of successful accomplishments, he was named Chief of Staff.
Previously, Mr. Oler practiced corporate law at the law firm of Kirkland & Ellis LLP. Prior to this, he was a financial research analyst at the Center for Financial Research & Analysis, and an investment banker with Lehman Brothers in London.
Mr. Oler holds a JD from Northwestern University School of Law with Distinction, an MBA from Kellogg School of Management with Distinction, and a Master of Science in Politics of the World Economy from the London School of Economics. He earned his undergraduate degrees, magna cum laude, from the Wharton School and the University of Pennsylvania.
What is Abraham N. Oler's net worth?
The estimated net worth of Abraham N. Oler is at least $0.00 as of November 25th, 2019. Mr. Oler owns 75,000 shares of Onconova Therapeutics stock worth more than $0 as of December 2nd. This net worth evaluation does not reflect any other assets that Mr. Oler may own. Learn More about Abraham N. Oler's net worth.
How do I contact Abraham N. Oler?
Has Abraham N. Oler been buying or selling shares of Onconova Therapeutics?
Who are Onconova Therapeutics' active insiders?
